WKRC: Local researchers working on a new potential way to treat eye diseases
UC led research may soon have a new kinder, gentler way to treat eye diseases.
UC drug delivery researcher Kevin Li, a professor in the James L. Winkle College of Pharmacy, takes the lead on new research looking for different ways to treat eye diseases such as macular degeneration and diabetic retinopathy. Currently, these diseases are treated with direct eye injections.
In an interview with WKRC, co-researcher Michael Yang, a pediatric ophthalmologist at Cincinnati Children’s Hospital Medical Center, explains how this federally funded study will seek alternatives to current drug delivery methods.
The study is a collaboration between UC, CCHMC and Ohio State University.
Featured image at top of eye. Photo/Victor Freitas/unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
OTR mural celebrates UC alumni success
April 4, 2025
The UC Alumni Association, UCAA, will mark its annual Alumni Celebration during its upcoming Alumni Week, April 7-13, with a community art project commemorating this year’s slate of alumni honorees receiving the organization’s top awards.
Study: Platform-predicted treatments improve outcomes for...
April 4, 2025
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that an assay that includes an assessment of cancer stem cell sensitivity to chemotherapy can accurately decide more effective treatments and lead to increased outcomes for patients with platinum-resistant ovarian cancer.
UC Alumni Week highlights excellence and engagement
April 4, 2025
Alumni Week, the UC Alumni Association’s spring spotlight on the alumni family, highlights the remarkable achievements and enormous impact of our alumni.